Literature DB >> 14678370

Does extended lymphadenectomy increase the morbidity of radical cystectomy?

C Brössner1, A Pycha, A Toth, C Mian, W Kuber.   

Abstract

OBJECTIVE: To report the events during and after radical cystectomy and urinary diversion for bladder cancer, in terms of major and minor complications, comparing a minimal with an extended lymphadenectomy, as more lymph nodes obtained during radical cystectomy may improve staging and thus the outcome. PATIENTS AND METHODS: We reviewed 92 consecutive patients who underwent radical cystectomy from March 1998 to February 2002; 46 had a minimal (group A) and 46 an extended lymphadenectomy (group B). Cases were selected according to the American Society of Anesthesiologists classification, only including those graded 2 or 3. We specifically evaluated the incidence and type of complications within 30 days after surgery.
RESULTS: Because of extending the lymphadenectomy the operative duration was a median of 63 min longer in group B (P < 0.01). Complications requiring surgical interventions occurred in four (9%) patients in group A and five (11%) in group B (P = 0.28). Complications requiring no surgical intervention were also similar in both groups. Three patients died, two in group A and one in group B (P = 0.57).
CONCLUSION: Extended lymphadenectomy in radical cystectomy does not increase the morbidity within 30 days of surgery.

Entities:  

Mesh:

Year:  2004        PMID: 14678370     DOI: 10.1111/j.1464-410x.2004.04557.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  25 in total

Review 1.  Extent of pelvic lymph node dissection during radical cystectomy: is bigger better?

Authors:  Debasish Sundi; Robert S Svatek; Matthew E Nielsen; Mark P Schoenberg; Trinity J Bivalacqua
Journal:  Rev Urol       Date:  2014

2.  Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.

Authors:  M May; C Protzel; M W Vetterlein; M Gierth; J Noldus; A Karl; T Grimm; B Wullich; M O Grimm; P Nuhn; P J Bastian; J Roigas; B Hadaschik; C Gilfrich; M Burger; M Fisch; S Brookman-May; A Aziz; O W Hakenberg
Journal:  Int Urol Nephrol       Date:  2016-11-28       Impact factor: 2.370

Review 3.  [Lymphadenectomy for bladder cancer: current status and controversies].

Authors:  T Metzger; G N Thalmann; P Zehnder
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

Review 4.  [The significance of extended pelvic lymphadenectomy in bladder cancer].

Authors:  M Autenrieth; M Retz; J E Gschwend
Journal:  Urologe A       Date:  2011-12       Impact factor: 0.639

5.  Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer.

Authors:  Hiroshi Kitamura; Fumiyasu Takei; Sachiyo Nishida; Takashi Muranaka; Naoya Masumori; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-05-25       Impact factor: 3.402

Review 6.  Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.

Authors:  Lars Weisbach; Roland Dahlem; Giuseppe Simone; Jens Hansen; Armin Soave; Oliver Engel; Felix K Chun; Shahrokh F Shariat; Margit Fisch; Michael Rink
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

7.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

8.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

9.  Lymphadenectomy in bladder cancer: What should be the extent?

Authors:  K Muruganandham; A Mandhani
Journal:  Indian J Urol       Date:  2010-07

10.  Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) program.

Authors:  Connor M Forbes; Ali Cyrus Chehroudi; Miles Mannas; Andrea Bisaillon; Tracey Hong; Alan I So; Kelly Mayson; Peter C Black
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.